Johnson & Johnson COVID-19 Vaccine Isn’t As Effective, But Has This Other Big Benefit
01/29/21 AT 8:59 AM
A third COVID-19 vaccine by Johnson & Johnson could be on the horizon, but while it could be beneficial to those who aren’t comfortable with the two doses needed by the Pfizer/BioNTech and Moderna vaccines, there is one major issue with the newest one to potentially hit the market its efficacy rate.
Following global clinical trials, the vaccine was proven to be 66% effective at preventing moderate and severe illness from COVID-19, according to The Washington Post. The trial found 85% efficacy at preventing severe disease overall and 72% effectiveness at preventing moderate to severe illness in the United States, but in areas where troubling new variants of the disease have emerged, the rate was much lower showing only 66% effectiveness in Latin America and 57% in South Africa.
State Disaster Medical Advisory Committee sends recommendations for Phase 1b vaccinations to state DHS.
Written By:
Brady Carlson / Wisconsin Public Radio | 4:00 pm, Jan. 22, 2021 ×
A vial of the Pfizer-BioNTech COVID-19 Vaccine at St. Luke s hospital in Duluth. (Clint Austin / 2020 file / News Tribune)
Educators and child care workers could receive priority over other groups of essential workers for COVID-19 vaccines, according to recommendations by a state panel.
The State Disaster Medical Advisory Committee at its Thursday, Jan. 21, meeting proposed giving priority within the state’s phase 1b vaccination group.
That group also includes people who work in public transit, employees of grocery stores and other parts of the food supply chain, utility workers, 911 operators, non-frontline health care workers, those in the mink industry, and people who live and work in correctional facilities.
Doctors join St. Luke s team
Five new doctors have joined the St. Luke s health care team. Scott Mikesell, DO, is now a member of St. Luke s Cardiology Associates. Jeffrey Speer, MD, is a member of St. Luke s Anesthesia Associates. And Brad Irwin, MD, Max Miranda, MD, recent.
Written By:
news@superiortelegram.com | 7:00 am, Oct. 15, 2010
Five new doctors have joined the St. Luke s health care team. Scott Mikesell, DO, is now a member of St. Luke s Cardiology Associates. Jeffrey Speer, MD, is a member of St. Luke s Anesthesia Associates. And Brad Irwin, MD, Max Miranda, MD, recently joined Drs. Waldo Avello and Aga Bednarz at St. Luke s Gastroenterology Associates, and Brigid Pajunen, MD, recently joined P.S. Rudie Medical Clinic, one of St. Luke s family medicine clinics, located at 26 E. Superior St., Duluth.
E-Mail
IMAGE: A and B, True-positive assessments in 58-year-old woman (A) and 52-year-old man (B) with high-risk NAFLD and associated NASH. CT images show hepatic enlargement, heterogeneously low-attenuation hepatic parenchyma, and surrounding. view more
Credit: American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)
Leesburg, VA, January 22, 2021 According to ARRS
American Journal of Roentgenology (AJR), Fibrosis-4 (FIB-4) and multiple CT findings can identify patients with high-risk nonalcoholic fatty liver disease (NAFLD) advanced fibrosis or cirrhosis, that is though the presence of nonalcoholic steatohepatitis (NASH) remains elusive on CT. Subjective assessment of multiple morphologic and separately quantified parameters by trained readers and a simple quantitative three-parameter model combining two CT features, liver surface nodularity (LSN) and liver segmental volume ratio (LSVR), and a clinical score (FIB-4) showed good association